Koller, Lorenz <br/><br/>
Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.  [electronic resource] 

 -  JACC. Heart failure  04 2017 
 - 268-277 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2213-1787 
<br/><br/><label>Standard No.: </label>10.1016/j.jchf.2016.12.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Cardiovascular Diseases--mortality<br/>Cause of Death<br/>Chronic Disease<br/>Cohort Studies<br/>Female<br/>Heart Failure--blood<br/>Humans<br/>Male<br/>Middle Aged<br/>Mortality<br/>Predictive Value of Tests<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptors, Urokinase Plasminogen Activator--blood<br/>Reproducibility of Results<br/>Risk Assessment